Homidium

Homidium

SCHEMBL31511751

CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 1.00
▸ KMT2A Q03164 5/20 1.00
▸ MAPT P10636 5/20 1.00
▸ BLM P54132 4/20 1.00
▸ KDM4E B2RXH2 4/20 1.00
▸ HPGD P15428 4/20 1.00
▸ HTT P42858 4/20 1.00
▸ CYP3A4 P08684 3/20 1.00
▸ THRB P10828 3/20 1.00
▸ CASP1 P29466 3/20 1.00
▸ RECQL P46063 3/20 1.00
▸ CASP7 P55210 3/20 1.00
▸ TERT O14746 3/20 1.00
▸ ALDH1A1 P00352 3/20 1.00
▸ MAPK1 P28482 3/20 1.00
▸ HSD17B10 Q99714 3/20 1.00
▸ MITF O75030 2/20 1.00
▸ NSD2 O96028 2/20 1.00
▸ LMNA P02545 2/20 1.00
▸ TP53 P04637 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Homidium SCHEMBL29391335 1.00 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL21647365 1.00 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL27609 1.00 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL11023665 0.99 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL3025214 0.99 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL612343 0.99 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL7751164 0.99 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL20520 0.99 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL1879927 0.99 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL19690770 0.99 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025226152-A1 CHARACTERIZATION OF CELLS SHANX MEDTECH BV (NL) 2025-10-30 — — WO disclosed
US-12234504-B1 High throughput screening assay to identify DNA topoisomerase inhibitors THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2025-02-25 — — US disclosed
Send feedback